Published in AIDS Weekly, May 1st, 2006
The company's 2005 revenues were $3.94 million, a 19% increase compared to 2004 revenues of $3.31 million. For 2005, the net loss attributable to common stockholders was $6.77 million or $0.88 per share compared to a net loss attributable to common stockholders of $5.04 million or $0.85 per share for 2004. The net loss attributable to common stockholders for 2005 and 2004 includes $3.52 million and $1.94 million, respectively in non-cash dividends to preferred stockholders.
Revenues for the fourth quarter of 2005 were $1.36 million, a 17% increase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.